Real-time enrollment status for this locally advanced or metastatic solid tumors harboring a ros1 or ntrk alteration clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 2:20 AM UTC
| NCT Number | NCT06716138 |
| Recruiting Status | Recruiting |
| Condition | Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK Alteration |
| Phase | PHASE1 |
| Target Enrollment | 96 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Avistone Biotechnology Co., Ltd. |
| Last Updated on CT.gov | March 13, 2026 (Mar 13, 2026) |
As of July 18, 2026: Clinical trial NCT06716138 is currently recruiting participants. This phase1 study for locally advanced or metastatic solid tumors harboring a ros1 or ntrk alteration is actively seeking new participants at 1 location across the United States. The study is sponsored by Avistone Biotechnology Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06716138 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06716138 was last updated Mar 13, 2026 (March 13, 2026). HelloStudys verifies this status automatically.